0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Corrections   |    
Corrections
Am J Psychiatry 2013;170:1218-1218. doi:10.1176/appi.ajp.2013.17010
View Author and Article Information

Copyright © 2013 by the American Psychiatric Association

text A A A

The authors of the article “Does Fetal Exposure to SSRIs or Maternal Depression Impact Infant Growth?” (Am J Psychiatry 2013, 170:485-493) discovered two errors that did not substantially affect any of the results or conclusions: 1) Two cases were misclassified as being exposed to SSRI; therefore the number of women in the SSRI exposure group during pregnancy was reduced from 46 to 44. This affects some of the values in Tables 1 and 2 and the SSRI data in Figure 1. 2) When the data were passed into the packaged programs for calculating the percentiles according to the CDC, the percentiles for sex were switched (1=female in our data; in CDC program 1=male) in Figure 2. Revised Tables 1 and 2 and Figures 1 and 2 accompany this correction notice in the online edition.

The only results that change meaningfully (but do not affect the conclusions) and are not covered by the tables are presented here:

“The values observed in our study group were compared with the population statistics from the Centers for Disease Control and Prevention (www.cdc.gov/growthcharts/clinical_charts.htm) (Figure 2). The median length and weight measurements in all exposure groups were within the interquartile range (25th to 75th percentiles) of the general population of infants; therefore, the study group is reasonably similar to the general population. The median head circumferences were within the interquartile range for all exposure groups with two exceptions: infants with no exposure or exposure to MDD exceeded the 75 th percentile at 52 weeks of age.”

and

“No significant association between prenatal SSRI or depression exposure and growth in weight, length, or head circumference was observed. The unadjusted analysis revealed no association of prenatal exposure to weight (p=0.84), length (p=0.40), or head circumference (p=0.16). After we controlled for the characteristics that differed between exposure groups (race, education, employment, marital status, parity, presence of lifetime anxiety disorder, infant sex, and preterm birth) and included presence of depression at each postpartum time point, no significant association of exposure with weight (p=0.40), length (p=0.76), or head circumference (p=0.72) was observed. In addition, because maternal body weight affects aspects of infant growth, we evaluated the interaction of group and prepregnancy BMI, which was also nonsignificant, and no synergistic effect was identified for weight (p=0.79), length (p=0.81), or head circumference (p=0.97).”

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 40.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 64.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 9.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 64.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles